ProPhase Labs, Inc. Quarterly report pursuant to Section 13 or 15(d)

Significant Customers (Details Narrative) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Net sales	$ 3,840	$ 2,766	$ 9,351	$ 6,735
Sales Revenue, Net [Member] \| Third Party Contract Manufacturing Customer One [Member]
Concentration risk, percentage	57.60%	33.00%	56.20%	44.20%
Sales Revenue, Net [Member] \| Third Party Contract Manufacturing Customer Two [Member]
Concentration risk, percentage	15.90%	30.10%	16.60%	27.20%
Sales Revenue, Net [Member] \| Third Party Contract Manufacturing Customer Three [Member]
Concentration risk, percentage		10.20%
Trade Receivable [Member] \| Customer One [Member]
Concentration risk, percentage			55.70%		70.00%
Trade Receivable [Member] \| Customer Two [Member]
Concentration risk, percentage			12.80%		14.00%
Trade Receivable [Member] \| Customer Three [Member]
Concentration risk, percentage			11.10%		11.00%